Skip to content
AiSeekAiSeek
Sign in
Nexentis Deploys MitoCareX Bio’s Computational Drug Discovery Infrastructure on Google CloudAI illustration
NewTechnologyReported 2026-10-07 19:32

Nexentis Deploys MitoCareX Bio’s Computational Drug Discovery Infrastructure on Google Cloud

Nexentis Technologies Inc. announced that its wholly owned subsidiary, MitoCareX Bio, has deployed its computational drug discovery infrastructure on Google Cloud Platform to enhance computational capacity, data governance, and operational flexibility.

In depthRead the in-depth story

Why it matters. MitoCareX Bio’s transition to Google Cloud will support its evolving drug discovery requirements and align computing capacity with program needs, potentially accelerating research and development.

01

Who it touches

  1. 1MitoCareX Bio
  2. ← ownsFact
    2Nexentis Technologies Inc.Company
02

Evidence

  • GGlobeNewswire public company newsCompany2026-10-07 19:32
    Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.
    View source
  • GGlobeNewswire public company newsCompany2026-10-07 19:32
    The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
    View source
  • GGlobeNewswire public company newsCompany2026-10-07 19:32
    MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary
    View source
  • GGlobeNewswire public company newsCompany2026-10-07 19:32
    Ness Ziona, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (“Nexentis”), (NASDAQ: NXTS) (“Nexentis” or the “Company”), today announced that MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary, now deploys its Computational Drug Discovery Infrastru…
    View source
  • GGlobeNewswire public company newsCompany2026-10-07 19:32
    For example, the Company is using forward-looking statements when it discusses the anticipated benefits of deploying MitoCareX's computational drug discovery infrastructure on Google Cloud Platform, the expected enhancement of computational capacity, data governance and operatio…
    View source